Eluxadoline

Eluxadoline is an amino acid amide obtained by the formal condensation of the carboxy group of 4-carbamoyl-2,6-dimethyl-L-phenylalanine with the secondary amino group of 2-methoxy-5-({[(1S)-1-(4-phenylimidazol-2-yl)ethyl]amino}methyl)benzoic acid. It has mixed opioid receptor activity and is used for treatment of irritable bowel syndrome with diarrhoea. Among its listed roles, it functions as a mu-opioid receptor agonist, a delta-opioid receptor antagonist, a kappa-opioid receptor agonist and a gastrointestinal drug. It belongs to the class of imidazoles, a methoxybenzoic acid, a member of benzamides, a L-phenylalanine derivative and an amino acid amide. It is grouped under the following drug class(es): Schedule IV controlled substances. Its therapeutic use is listed as antidiarrheals. The directory classifies it as a commercial API with a peptide source/manufacturing origin. Other names for this substance include Viberzi and truberzi. It is listed as a controlled drug substance (Schedule IV). Its PubChem CID is 11250029.

CAS No 864821-90-9
Molecular Formula C32H35N5O5
Molecular Weight 569.6 g/mol
Synonyms 5-[[[(2S)-2-amino-3-(4-carbamoyl-2,6-dimethylphenyl)propanoyl]-[(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid

Frequently Asked Questions